Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the COMPARE program
- 1 March 1995
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 49 (7) , 947-954
- https://doi.org/10.1016/0006-2952(95)00009-o
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Multicenter phase II study of brequinar sodium in patients with advanced lung cancerCancer Chemotherapy and Pharmacology, 1993
- Neural Computing in Cancer Drug Development: Predicting Mechanism of ActionScience, 1992
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJNCI Journal of the National Cancer Institute, 1991
- Structure-activity relationship of quinoline carboxylic acidsBiochemical Pharmacology, 1990
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE AlgorithmJNCI Journal of the National Cancer Institute, 1989
- Low cytidine deaminase levels in human hematopoietic cell linesLeukemia Research, 1987
- The cellular location of dihydroorotate dehydrogenase: Relation to de novo biosynthesis of pyrimidinesArchives of Biochemistry and Biophysics, 1976